caggiati patrizia

Dr. caggiati patrizia


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2024 in Genes
Verified
Journal Article
Open access
PDF file
VBValeria Barili
Valeria Barili
EAEnrico Ambrosini
Enrico Ambrosini
BBBeatrice Bortesi
Beatrice Bortesi
RMRoberta Minari
Roberta Minari
ESErika De Sensi
Erika De Sensi
BPBenedetta Pellegrino
Benedetta Pellegrino
Germline variants occurring in BRCA1 and BRCA2 give rise to hereditary breast and ovarian cancer (HBOC) syndrome, predisposing to breast, ovarian, fallopian tube, and peritoneal cancers marked by elevated incidences of genomic aberrations that correspond to poor prognoses. These genes are in fact involved in genetic integrity, particularly in the process of homologous recombination (HR) DNA repair, a high-fidelity repair system for mending DNA double-strand breaks. In addition to its implication in HBOC pathogenesis, the impairment of HR has become a prime target for therapeutic intervention utilizing poly (ADP-ribose) polymerase (PARP) inhibitors. In the present review, we introduce the molecular roles of HR orchestrated by BRCA1 and BRCA2 within the framework of sensitivity to PARP inhibitors. We examine the genetic architecture underneath breast and ovarian cancer ranging from high- and mid- to low-penetrant predisposing genes and taking into account both germline and somatic variations. Finally, we consider higher levels of complexity of the genomic landscape such as polygenic risk scores and other approaches aiming to optimize therapeutic and preventive strategies for breast and ovarian cancer.

10 June 2023 in Genes
Verified
Journal Article
Open access
PDF file
VBValeria Barili
Valeria Barili
EAEnrico Ambrosini
Enrico Ambrosini
VUVera Uliana
Vera Uliana
MBMelissa Bellini
Melissa Bellini
GVGiulia Vitetta
Giulia Vitetta
Antonio PercesepeAntonio Percesepe
Antonio Percesepe
Novel approaches to uncover the molecular etiology of neurodevelopmental disorders (NDD) are highly needed. Even using a powerful tool such as whole exome sequencing (WES), the diagnostic process may still prove long and arduous due to the high clinical and genetic heterogeneity of these conditions. The main strategies to improve the diagnostic rate are based on family segregation, re-evaluation of the clinical features by reverse-phenotyping, re-analysis of unsolved NGS-based cases and epigenetic functional studies. In this article, we described three selected cases from a cohort of patients with NDD in which trio WES was applied, in order to underline the typical challenges encountered during the diagnostic process: (1) an ultra-rare condition caused by a missense variant in MEIS2, identified through the updated Solve-RD re-analysis; (2) a patient with Noonan-like features in which the NGS analysis revealed a novel variant in NIPBL causing Cornelia de Lange syndrome; and (3) a case with de novo variants in genes involved in the chromatin-remodeling complex, for which the study of the epigenetic signature excluded a pathogenic role. In this perspective, we aimed to (i) provide an example of the relevance of the genetic re-analysis of all unsolved cases through network projects on rare diseases; (ii) point out the role and the uncertainties of the reverse phenotyping in the interpretation of the genetic results; and (iii) describe the use of methylation signatures in neurodevelopmental syndromes for the validation of the variants of uncertain significance.

23 May 2025 in Genes
Verified
Journal Article
Open access
PDF file
BMBarbara Moschella
Barbara Moschella
SBSabrina Busciglio
Sabrina Busciglio
EAEnrico Ambrosini
Enrico Ambrosini
SCSofia Cesarini
Sofia Cesarini
LCLuca Caramanna
Luca Caramanna
Antonio PercesepeAntonio Percesepe
Antonio Percesepe
Darier′s disease (DD) is a rare, autosomal dominant genodermatosis caused by pathogenic variants in the ATP2A2 gene, which encodes the SERCA2 protein, an endoplasmic reticulum ATPase Ca2+ transporter. These mutations impair the intracellular calcium homeostasis leading to increased protein misfolding, endoplasmic reticulum (ER) stress response, and the activation of the unfolded protein response (UPR), culminating in keratinocyte apoptosis and anomalies in interfollicular epidermal stratification. Clinically, the disease is characterized by the presence of skin lesions with hyperkeratotic papules and an increased susceptibility to inflammatory reactions, bacterial and viral infections. The histological hallmarks include acantholysis, dyskeratosis, and increased apoptotic keratinocytes, referred to as “corp ronds”. The SERCA2b isoform is expressed not only in the epidermis but it is present ubiquitously in all tissues, suggesting that its alteration may have multi-organ effects. The review aims to provide a broad overview of the pathology, from intracellular dysfunction to the clinical manifestations, elucidating the molecular effects of SERCA2 variants found in DD patients and exploring the potential cell signaling pathways that may contribute to disease progression. Beginning with an examination of the cellular alterations, our work then shifts to exploring their impact in an organ-specific context, providing insights into new potential therapeutic strategies tailored to clinical manifestations.

Verified
Journal Article
Open access
PDF file
ICIlenia Rita Cannizzaro
Ilenia Rita Cannizzaro
Mirko TreccaniMirko Treccani
Mirko Treccani
ATAntonietta Taiani
Antonietta Taiani
EAEnrico Ambrosini
Enrico Ambrosini
SBSabrina Busciglio
Sabrina Busciglio
VBValeria Barili
Valeria Barili
Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disorder characterized by the predisposition to develop tumors such as malignant peripheral nerve sheath tumors (MPNSTs) which represents the primary cause of death for NF1-affected patients. Regardless of the high incidence and mortality, the molecular mechanisms underneath MPNST growth and metastatic progression remain poorly understood. In this proof-of-concept study, we performed somatic whole-exome sequencing (WES) to profile the genomic alterations in four samples from a patient with NF1-associated MPNST, consisting of a benign plexiform neurofibroma, a primary MPNST, and metastases from lung and skin tissues. By comparing genomic patterns, we identified a high level of variability across samples with distinctive genetic changes which allow for the definition of profiles of the early phase with respect to the late metastatic stages. Pathogenic and likely pathogenic variants were abundant in the primary tumor, whereas the metastatic samples exhibited a high level of copy-number variations (CNVs), highlighting a possible genomic instability in the late phases. The most known MPNST-related genes, such as TP53 and SUZ12, were identified in CNVs observed within the primary tumor. Pathway analysis of altered early genes in MPNST pointed to a potential role in cell motility, division and metabolism. Moreover, we employed survival analysis with the TCGA sarcoma genomic dataset on 262 affected patients, in order to corroborate the predictive significance of the identified early and metastatic MPNST driver genes. Specifically, the expression changes related to the mutated genes, such as in RBMX, PNPLA6 and AGAP2, were associated with reduced patient survival, distinguishing them as potential prognostic biomarkers. This study underlines the relevance of integrating genomic results with clinical information for early diagnosis and prognostic understanding of tumor aggressiveness.

1 June 2026 in ACG Case Reports Journal
Verified
Journal Article
Open access
DMDaniele Macchi
Daniele Macchi
ECEleonora Cortellazzi
Eleonora Cortellazzi
VUVera Uliana
Vera Uliana
EAEnrico Ambrosini
Enrico Ambrosini
FNFrancesca Negri
Francesca Negri
SKStefano Kayali
Stefano Kayali
Nth-like DNA glycosylase 1-associated tumor syndrome (NATS) is a rare autosomal recessive cancer predisposition syndrome linked to colorectal, endometrial and ovarian cancers. Given its recent description in 2015, the full spectrum of benign manifestations remains uncertain. We describe a 53-year-old man with a biallelic pathogenic Nth-Like DNA Glycosylase 1 variant, c.244C>T(p.Gln82*), duodenal and colonic adenomas, and an unusual aggregation of benign neoplasms, including multiple oral, hepatic, splenic, and vertebral hemangiomas, an esophageal lipoma, schwannomas, and meningiomas. This represents the first report of schwannomas and oral or vertebral hemangiomas in biallelic NATS, expanding the phenotypic spectrum and supporting consideration of NATS in patients with colorectal polyposis and clustered benign neurovascular tumors.